Skip to main content
. 2017 Mar 9;1(3):223–229. doi: 10.1007/s41669-017-0016-5
This study aimed to assess the cost impact of implementing a new therapeutic strategy for treating anaemia in patients undergoing dialysis.
Treating anaemia with methoxy polyethylene glycol-epoetin beta in patients undergoing haemodialysis may reduce costs related to the management of these patients in a hospital environment.